Single Dose of Ivermectin is not Useful in Patients with Hematological Disorders and COVID-19 Illness: A Phase II B Open Labelled Randomized Controlled Trial

DOI record: { "DOI": "10.1007/s12288-022-01546-w", "ISSN": [ "0971-4502", "0974-0449" ], "URL": "http://dx.doi.org/10.1007/s12288-022-01546-w", "alternative-id": [ "1546" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "8 February 2022" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "26 April 2022" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "27 May 2022" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Conflict of interest", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "No conflicts of interest to declare for any of the authors." }, { "label": "Free to read", "name": "free", "value": "This content has been made available to all." } ], "author": [ { "ORCID": "http://orcid.org/0000-0002-9847-9501", "affiliation": [], "authenticated-orcid": false, "family": "George", "given": "Biju", "sequence": "first" }, { "affiliation": [], "family": "Moorthy", "given": "Mahesh", "sequence": "additional" }, { "affiliation": [], "family": "Kulkarni", "given": "Uday", "sequence": "additional" }, { "affiliation": [], "family": "Selvarajan", "given": "Sushil", "sequence": "additional" }, { "affiliation": [], "family": "Rupali", "given": "Priscilla", "sequence": "additional" }, { "affiliation": [], "family": "Christopher", "given": "D. J.", "sequence": "additional" }, { "affiliation": [], "family": "Balamugesh", "given": "T.", "sequence": "additional" }, { "affiliation": [], "family": "Rose", "given": "Winsley", "sequence": "additional" }, { "affiliation": [], "family": "Lakshmi", "given": "Kavitha M.", "sequence": "additional" }, { "affiliation": [], "family": "Devasia", "given": "Anup J.", "sequence": "additional" }, { "affiliation": [], "family": "Fouzia", "given": "N. A.", "sequence": "additional" }, { "affiliation": [], "family": "Korula", "given": "Anu", "sequence": "additional" }, { "affiliation": [], "family": "Lionel", "given": "Sharon", "sequence": "additional" }, { "affiliation": [], "family": "Abraham", "given": "Aby", "sequence": "additional" }, { "affiliation": [], "family": "Mathews", "given": "Vikram", "sequence": "additional" } ], "container-title": "Indian Journal of Hematology and Blood Transfusion", "container-title-short": "Indian J Hematol Blood Transfus", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2022, 5, 27 ] ], "date-time": "2022-05-27T06:02:46Z", "timestamp": 1653631366000 }, "deposited": { "date-parts": [ [ 2022, 5, 27 ] ], "date-time": "2022-05-27T07:23:39Z", "timestamp": 1653636219000 }, "funder": [ { "DOI": "10.13039/501100001843", "award": [ "CVD/2020/000990" ], "doi-asserted-by": "publisher", "name": "Science and Engineering Research Board" } ], "indexed": { "date-parts": [ [ 2022, 5, 27 ] ], "date-time": "2022-05-27T07:41:20Z", "timestamp": 1653637280094 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2022, 5, 27 ] ] }, "language": "en", "license": [ { "URL": "https://www.springer.com/tdm", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 5, 27 ] ], "date-time": "2022-05-27T00:00:00Z", "timestamp": 1653609600000 } }, { "URL": "https://www.springer.com/tdm", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 5, 27 ] ], "date-time": "2022-05-27T00:00:00Z", "timestamp": 1653609600000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1007/s12288-022-01546-w.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1007/s12288-022-01546-w/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1007/s12288-022-01546-w.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "prefix": "10.1007", "published": { "date-parts": [ [ 2022, 5, 27 ] ] }, "published-online": { "date-parts": [ [ 2022, 5, 27 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.1016/S0140-6736(20)31187-9", "author": "NM Kuderer", "doi-asserted-by": "publisher", "first-page": "1907", "issue": "395", "journal-title": "Lancet", "key": "1546_CR1", "unstructured": "Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR et al (2020) Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 20(395):1907–1918", "volume": "20", "year": "2020" }, { "DOI": "10.1016/S1470-2045(20)30096-6", "author": "W Liang", "doi-asserted-by": "publisher", "first-page": "335", "issue": "3", "journal-title": "Lancet Oncol", "key": "1546_CR2", "unstructured": "Liang W, Guan W, Chen R, Wang W, Li J, Xu K et al (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337", "volume": "21", "year": "2020" }, { "author": "LYW Lee", "first-page": "1907", "issue": "395", "journal-title": "Lancet", "key": "1546_CR3", "unstructured": "Lee LYW, Cazier J-B, Angelis V, Arnold R, Bisht V, Campton NA et al (2020) COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 20(395):1907–1926", "volume": "20", "year": "2020" }, { "DOI": "10.1016/S2352-3026(20)30251-9", "author": "F Passamonti", "doi-asserted-by": "publisher", "first-page": "e737", "issue": "10", "journal-title": "Lancet Haematol", "key": "1546_CR4", "unstructured": "Passamonti F, Cattaneo C, Arcaini L et al (2020) Clinical characteristics and risk factors associated with COVID-19 severity in patients with hematological malignancies in Italy: a retrospective multicenter cohort study. Lancet Haematol 7(10):e737–e745", "volume": "7", "year": "2020" }, { "DOI": "10.1186/s40164-020-00177-z", "author": "JL Pinana", "doi-asserted-by": "publisher", "first-page": "21", "journal-title": "Exp Hematol Oncol", "key": "1546_CR5", "unstructured": "Pinana JL, Martino R, Garcia IG et al (2020) Risk factors and outcomes of COVID19 in patients with hematological malignancies. Exp Hematol Oncol 9:21. https://doi.org/10.1186/s40164-020-00177-z", "volume": "9", "year": "2020" }, { "DOI": "10.1056/NEJMc2001737", "author": "L Zou", "doi-asserted-by": "publisher", "first-page": "1177", "issue": "12", "journal-title": "NEJM", "key": "1546_CR6", "unstructured": "Zou L, Ruan F, Huang M et al (2020) SARS-CoV-2 Viral Load in Upper Respiratory Specimens of infected patients. NEJM 382(12):1177–1179", "volume": "382", "year": "2020" }, { "DOI": "10.1016/S1473-3099(20)30232-2", "author": "Y Liu", "doi-asserted-by": "publisher", "first-page": "656", "issue": "6", "journal-title": "Lancet Infect Dis", "key": "1546_CR7", "unstructured": "Liu Y, Yan L-M, Wan L, Xiang T-X, Le A, Liu J-M et al (2020) Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis 20(6):656–657", "volume": "20", "year": "2020" }, { "DOI": "10.1164/rccm.202003-0524LE", "author": "D Chang", "doi-asserted-by": "publisher", "first-page": "1150", "issue": "9", "journal-title": "Am J Respir Crit Care Med", "key": "1546_CR8", "unstructured": "Chang D, Mo G, Yuan X, Tao Y, Peng X, Wang F et al (2020) Time kinetics of viral clearance and resolution of symptoms in novel coronavirus infection. Am J Respir Crit Care Med 201(9):1150–1152", "volume": "201", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30566-3", "author": "F Zhou", "doi-asserted-by": "publisher", "first-page": "1054", "issue": "10229", "journal-title": "Lancet", "key": "1546_CR9", "unstructured": "Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062", "volume": "395", "year": "2020" }, { "DOI": "10.3390/v13060989", "author": "AA Samaha", "doi-asserted-by": "publisher", "first-page": "989", "issue": "6", "journal-title": "Viruses", "key": "1546_CR10", "unstructured": "Samaha AA, Mouawia H, Fawaz M et al (2021) Effects of a single dose of ivermectin on viral and clinical outcomes in asymptomatic SARS—Cov 2 infected subjects: a pilot clinical trial in Lebanon. Viruses 13(6):989", "volume": "13", "year": "2021" }, { "DOI": "10.1136/bmj.n949", "author": "JJ Bartoszko", "doi-asserted-by": "publisher", "first-page": "n949", "journal-title": "BMJ", "key": "1546_CR11", "unstructured": "Bartoszko JJ, Siemieniuk RAC, Kum E et al (2021) Prophylaxis against COVID-19: living systematic review and network meta-analysis. BMJ 373:n949. https://doi.org/10.1136/bmj.n949", "volume": "373", "year": "2021" }, { "DOI": "10.1016/j.eclinm.2020.100720", "author": "C Chaccour", "doi-asserted-by": "publisher", "first-page": "100720", "journal-title": "E Clin Med", "key": "1546_CR12", "unstructured": "Chaccour C, Casellas A, Di Matteo AB et al (2021) The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trial. E Clin Med 32:100720. https://doi.org/10.1016/j.eclinm.2020.100720", "volume": "32", "year": "2021" }, { "DOI": "10.1001/jama.2021.3071", "author": "E Lopez-Medina", "doi-asserted-by": "publisher", "first-page": "1426", "issue": "14", "journal-title": "JAMA", "key": "1546_CR13", "unstructured": "Lopez-Medina E, Lopez P, Hurtado IC et al (2021) Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19: a randomized clinical trial. JAMA 325(14):1426–1435", "volume": "325", "year": "2021" }, { "DOI": "10.1002/jmv.27122", "author": "S Abd-Elsalam", "doi-asserted-by": "publisher", "journal-title": "J Med Virol", "key": "1546_CR14", "unstructured": "Abd-Elsalam S, Noor RA, Badawi R et al (2021) Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: a randomized controlled study. J Med Virol. https://doi.org/10.1002/jmv.27122", "year": "2021" }, { "DOI": "10.1016/j.clinthera.2021.04.007", "author": "L Shahbaznejad", "doi-asserted-by": "publisher", "journal-title": "Clin Ther", "key": "1546_CR15", "unstructured": "Shahbaznejad L, Davoudi A, Eslami G et al (2021) Effects of ivermectin in patients with COVID-19: a multicenter, double-blind, randomized, controlled clinical trial. Clin Ther. https://doi.org/10.1016/j.clinthera.2021.04.007", "year": "2021" }, { "DOI": "10.1177/03000605211013550", "author": "R Mahmud", "doi-asserted-by": "publisher", "first-page": "300060521101355", "issue": "5", "journal-title": "J Int Med Res", "key": "1546_CR16", "unstructured": "Mahmud R, Rahman MM, Alam I et al (2021) Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial. J Int Med Res 49(5):3000605211013550. https://doi.org/10.1177/03000605211013550", "volume": "49", "year": "2021" }, { "DOI": "10.3390/v13030436", "author": "MM Biernat", "doi-asserted-by": "publisher", "first-page": "436", "issue": "3", "journal-title": "Viruses", "key": "1546_CR17", "unstructured": "Biernat MM, Kolasinska A, Kwiatkowski J et al (2021) Early administration of convalescent plasma improves survival in patients with hematological malignancies and COVID 19. Viruses 13(3):436", "volume": "13", "year": "2021" }, { "DOI": "10.1182/blood.2020008423", "author": "T Hueso", "doi-asserted-by": "publisher", "first-page": "2290", "issue": "20", "journal-title": "Blood", "key": "1546_CR18", "unstructured": "Hueso T, Pouderoux C, Pere H et al (2020) Convalescent plasma therapy for B cell depleted patients with protracted COVID-19. Blood 136(20):2290–2295", "volume": "136", "year": "2020" }, { "DOI": "10.1016/j.transci.2021.103075", "author": "P Jeyaraman", "doi-asserted-by": "publisher", "first-page": "103075", "journal-title": "Transfus Apher Sci", "key": "1546_CR19", "unstructured": "Jeyaraman P, Agrawal N, Bhargava R et al (2021) Convalescent plasma therapy for severe COVID 19 in patients with hematological malignancies. Transfus Apher Sci 60:103075", "volume": "60", "year": "2021" }, { "DOI": "10.1007/s00277-020-04160-w", "author": "C Villegas", "doi-asserted-by": "publisher", "first-page": "2953", "issue": "12", "journal-title": "Ann Hematol", "key": "1546_CR20", "unstructured": "Villegas C, Poza M, Talayero P et al (2020) IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-Cov-2 infection. Ann Hematol 99(12):2953–2956", "volume": "99", "year": "2020" }, { "DOI": "10.1016/j.antiviral.2020.104787", "author": "L Caly", "doi-asserted-by": "publisher", "first-page": "104787", "journal-title": "Antiviral Res", "key": "1546_CR21", "unstructured": "Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM (2020) The FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 178:104787", "volume": "178", "year": "2020" }, { "DOI": "10.1016/j.ijid.2020.11.191", "author": "S Ahmed", "doi-asserted-by": "publisher", "first-page": "214", "journal-title": "Int J Infect Dis", "key": "1546_CR22", "unstructured": "Ahmed S, Karim MM, Ross AG et al (2021) A five-day course of ivermectin for the treatment of COVID 19 may reduce the duration of illness. Int J Infect Dis 103:214–216", "volume": "103", "year": "2021" }, { "DOI": "10.1186/s12879-021-06104-9", "author": "N Okamus", "doi-asserted-by": "publisher", "first-page": "411", "issue": "1", "journal-title": "BMC Infect Dis", "key": "1546_CR23", "unstructured": "Okamus N, Nemirturk N, Cetinkaya RA et al (2021) Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID 19 patients. BMC Infect Dis 21(1):411", "volume": "21", "year": "2021" } ], "reference-count": 23, "references-count": 23, "relation": {}, "resource": { "primary": { "URL": "https://link.springer.com/10.1007/s12288-022-01546-w" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Hematology" ], "subtitle": [], "title": "Single Dose of Ivermectin is not Useful in Patients with Hematological Disorders and COVID-19 Illness: A Phase II B Open Labelled Randomized Controlled Trial", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy" }